🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic cancer.

“The shining star of our family has faded away for us in this life,” his family confirmed. “After a lengthy and brave battle with the disease, we are deeply saddened to announce that Michael D’Angelo Archer, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on the music industry with his pioneering modern soul style and collaborations with renowned musicians.

He launched his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The album achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum soon after, and earned several award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The record premiered at No. 1 on both Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a reluctant one, in the public consciousness. The intimate portrayal showed the singer, notably stripped down to his waist, performing directly into the lens.

D’Angelo stepped back from the public eye after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious car crash that left him in critical condition.

More than a decade later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with another No. 1 debut on the R&B chart and a award for Top R&B Record.

Again, in his own mysterious fashion, D’Angelo had limited public appearances in the following years.

The musician was announced as a headliner for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s well-being in the weeks leading up to his death, he had reportedly been hospitalized for months and in hospice for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and hardest to prevent types of the illness, on a brilliant talent whose existence was ended too soon.

“We are grieved that he can only leave cherished moments with his loved ones, but we are eternally grateful for the legacy of extraordinarily moving music he leaves behind,” his family said.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic cancer impacts the digestive organ, a tiny gland that produces insulin and is vital in digestion, among other functions. The size and location of the pancreas in the human system make it more challenging to identify malignancy.

Although this cancer accounts for only about 3% of cancer diagnoses each year in the U.S., it is causes 7% of cancer deaths.

Almost seventy thousand people will be found to have this condition and roughly fifty-two thousand will die of the illness in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have few and poor therapies, and a smaller window to make a significant difference on the well-being of people,” noted a medical oncologist.

Because this disease rarely causes initial signs, it’s often diagnosed only after the disease is advanced. Even when a patient has symptoms they are often nonspecific and may be mistaken for a several common illnesses.

“Currently, there is no effective method to detect this malignancy in the initial phases, except for listening to your body and speaking with your doctor if there are new or unusual symptoms,” explained a medical director.

Frequent indicators of pancreatic cancer include:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as this malignancy is typically found in individuals in the 65 to 75 age bracket. However, numerous malignancies, such as pancreatic cancer, have become more common in younger people.

“Pancreatic cancer identified before the age of 50 is deemed uncommon, yet alarmingly, clinicians are beginning to see a rising count of younger patients suffering from this disease,” commented a expert.

Genetic Background Impacts Disease Probability

In the absence of reliable detection methods for this malignancy, experts stressed the importance of understanding your family’s health background. Some contributing elements, such as smoking and excess weight also play a role in the development of this disease.

African Americans have the greatest occurrence of this malignancy in the United States and are most likely to be found to have untreatable disease.

“The first step toward reducing one’s chance of pancreatic cancer is understanding personal risk factors. Individuals should review their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or overweight that may increase their susceptibility,” advised a specialist.

Hereditary risk factors are associated with as much as ten percent of all pancreatic cancer cases. If a relative in your family has had this disease, you may want to think about DNA analysis.

“For people with a family history of this condition or those carrying elevated risk DNA changes, checking may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to find early changes in the pancreas,” he explained.

For those wishing to reduce their risk, lifestyle changes may have an effect. The most effective action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Excessive drinking is associated with pancreas inflammation, a risk factor for this malignancy, so limiting or abstaining from drinks may assist lower your chance.

Controlling your body mass or shedding pounds may also help reduce your risk. People with obesity are twenty percent more prone to develop this disease. Pancreatic cancer also is more frequent in people with blood sugar issues, and reducing weight can also lower the risk of adult-onset diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and more recent combination chemotherapy. There are developing targeted therapies that already are making an impact,” said a specialist.

For numerous people, however, awareness about this rare but {dev